INTEGRA LIFESCIENCES HOLDINGS CORP Deferred Tax Assets, Valuation Allowance
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Deferred Tax Assets, Valuation Allowance of $22.60 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $22.60M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $15.50M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $12.49M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $9.65M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $22.60M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $15.50M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $12.49M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $9.65M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $9.77M 10-K · filed 2023-02-22 | |
| 2021-06-30 | $3.40M 10-Q · filed 2021-07-29 | |
| 2020-12-31 | $9.90M 10-K · filed 2022-02-24 | |
| 2020-06-30 | $3.40M 10-Q · filed 2021-07-29 | |
| 2020-03-31 | $3.30M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $9.87M 10-K · filed 2021-02-23 | |
| 2018-12-31 | $6.97M 10-K · filed 2020-02-21 | |
| 2017-12-31 | $8.00M 10-K · filed 2020-02-21 | $7.96M 10-K · filed 2018-03-01 |
| 2016-12-31 | $3.60M 10-K · filed 2019-02-26 | $3.60M 10-K · filed 2017-02-23 |
| 2015-12-31 | $4.90M 10-K · filed 2018-03-01 | |
| 2014-12-31 | $6.80M 10-K · filed 2017-02-23 | $7.30M 10-K · filed 2015-02-27 |
| 2013-12-31 | $7.30M 10-K · filed 2016-02-26 | $9.00M 10-K · filed 2014-02-27 |
| 2012-12-31 | $14.20M 10-K · filed 2015-02-27 | |
| 2011-12-31 | $32.30M 8-K · filed 2014-06-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |